Somatic GATA2 mutations are also seen in hematopoietic malignancies with a strong association with acute myeloid leukemia (AML) with bi-allelic CEBPA mutations, or reduced expression of CEBPA such as in AML with t(8;21) (Greif et al., 2012; Christen et al., 2019). This evidence concerns the gene GATA2 and acute myeloid leukemia.